Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

GSK Plans U.K.-Wide Bexsero Vaccination Campaign, Sells Other Meningitis Vaccines To Pfizer

This article was originally published in The Pink Sheet Daily

Executive Summary

Two vaccination campaigns will start in the U.K. this summer, one featuring GSK’s meningitis B vaccine Bexsero, recently acquired from Novartis, and the other vaccines against a growing threat from W strain meningococcus, as GSK plans to divest its own meningitis vaccines to Pfizer.


Related Content

Swapping Assets Now Down To Execution For GSK And Novartis
Pressure For Bexsero: Fate Of Novartis Vaccines Unit Hangs On Success


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst